Is there a need to reconsider the use of metformin in COVID-19 patients with type 2 diabetes mellitus?

ConclusionsOur findings indicated that metformin may be safely continued in COVID-19 patients. The benefit of metformin therapy with simultaneous continuous monitoring of COVID-19 severity and kidney function may outweigh the risks of lactic acidosis, of which incidence is relatively rare.

http://link.springer.com/10.1007/s13410-021-00924-w

Source: International Journal of Diabetes in Developing Countries - March 2, 2021 Category: Endocrinology Source Type: research